Mexico Flow Cytometry Market Size & Outlook, 2023-2030

The flow cytometry market in Mexico is expected to reach a projected revenue of US$ 83.8 million by 2030. A compound annual growth rate of 7.5% is expected of Mexico flow cytometry market from 2024 to 2030.
Revenue, 2023 (US$M)
$50.6
Forecast, 2030 (US$M)
$83.8
CAGR, 2024 - 2030
7.5%
Report Coverage
Mexico

Mexico flow cytometry market highlights

  • The Mexico flow cytometry market generated a revenue of USD 50.6 million in 2023 and is expected to reach USD 83.8 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
  • In terms of segment, instruments was the largest revenue generating product in 2023.
  • Software is the most lucrative product segment registering the fastest growth during the forecast period.


Flow cytometry market data book summary

Market revenue in 2023USD 50.6 million
Market revenue in 2030USD 83.8 million
Growth rate7.5% (CAGR from 2023 to 2030)
Largest segmentInstruments
Fastest growing segmentSoftware
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents & Consumables, Software, Accessories, Services
Key market players worldwideDanaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp


Other key industry trends

  • In terms of revenue, Mexico accounted for 1.2% of the global flow cytometry market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 83.8 million by 2030.

Instruments was the largest segment with a revenue share of 34.78% in 2023. Horizon Databook has segmented the Mexico flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.


Mexico is the third-largest pharmaceutical market in Latin America. Mexico has emerged as one of the potential countries for biopharmaceutical products owing to the presence of skilled scientists, low manufacturing costs, and advanced legal framework. Moreover, high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology sector.

In addition, the Mexican government has prioritized growth and innovation in the biotechnology sector. Thus, growing biopharmaceutical and biotechnology industries in the country are anticipated to create high demand for flow cytometry products in the region and support market growth.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Flow Cytometry Market Companies

Name Profile # Employees HQ Website

Mexico flow cytometry market size, by product, 2018-2030 (US$M)

Mexico Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)

Mexico flow cytometry market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more